FDA: All Ranitidine Products Must Be Removed From the Market
According to the results of tests conducted by the Agency, NDMA levels in ranitidine products can increase over time under normal storage conditions.
General Oncology
A Clinical Registry for the Rapid Collection of Data: The COVID-19 and Cancer Consortium
The design of the COVID-19 and Cancer Consortium (CCC19) is similar to that of the Genomics Evidence Neoplasia Information Exchange (GENIE) from AACR.
RACE for Children Act Could Substantially Increase Studies of Pediatric Cancer Drugs
An analysis of previously approved novel anticancer agents estimates that more than 78% would have met the RACE for Children Act criteria for pediatric testing.
Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.
Cancer Organization Asks White House to Waive Cancer-Related Prior Authorizations
Work from home administrative staff may not have capabilities to obtain authorizations.
Young Cancer Survivors Have More Financial, Food Insecurity
Cancer survivors aged 18 to 39 have consistently higher ‘very worried’ levels about retirement, bills.
Concerns Related to Food Access, Nonmedical Expenses Higher in Younger Cancer Survivors Compared With Older Survivors
Increasing attention is being paid to social determinants of health in cancer survivors.
Large Consortium Study Reveals More Details on the Link Between Viruses and Cancer
Researchers use whole-genome and whole-transcriptome sequencing data to reveal viral sequences in cancer tissue.
Combating COVID-19: Best Practices That Clinicians Need to Know
How should clinicians combat coronavirus disease (COVID-19) in their practice settings?
Current Best Practices to Facilitate the Management of COVID-19 at Cancer Care Institutions
The authors of this article described the COVID-19 crisis as the “health care challenge of our generation.”
Next post in General Oncology
